CD35 (EP197) Rabbit Monoclonal Primary Antibody
Specialties: Anatomic Pathology Hematopathology
CD35, complement receptor 1, is a cell membrane-bound, monomeric glycoprotein on numerous cell types including erythrocytes, leukocytes, glomerular podocytes, and follicular dendritic cells. The primary function of CD35 is to serve as the cellular receptor for C3b and C4b, the most important components of the complement system leading to clearance of foreign macromolecules. The Knops blood group system is a system of antigens located on this protein. The protein mediates cellular binding to particles and immune complexes that have activated complement. Follicular dendritic cells (FDC) are restricted to the B-cell regions of secondary lymphoid follicles. CD35 antigen is found on erythrocytes, B cells, a subset of T cells, monocytes, as well as eosinophils, and neutrophils. Anti-CD35 is considered a mature B-cell marker which labels follicular dendritic reticulum cells and tumors derived from such cells such as follicular dendritic cell tumor/sarcoma.1-6
- Dillon KM, et al. Mediastinal mixed dendritic cell sarcoma with hybrid features. J Clin Pathol. 2002; 55:791-4.
- Pileri SA, et al. Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology. 2002; 41:1-29.
- Maeda K, et al. Immunohistochemical recognition of human follicular dendritic cells (FDCs) in routinely processed paraffin sections. J Histochem Cytochem. 2002; 50:1475-86.
- Biddle DA, et al. Extranodal follicular dendritic cell sarcoma of the head and neck region: three new cases, with a review of the literature. Mod Pathol 2002; 15:50-8.
- Cheuk W, et al. Inflammatory pseudotumor-like follicular dendritic cell tumor: a distinctive low-grade malignant intra-abdominal neoplasm with consistent Epstein-Barr virus association. Am J Surg Pathol. 2001; 25:721-31.
- Chang KC, et al. Germinal centre-like versus undifferentiated stromal immunophenotypes in follicular lymphoma. J Pathol. 2003; 201:404-12.
Specifications
- Reactivity: paraffin
- Control: Tonsil (Membranous)
- Dilution Range: 1:25-1:100 *
Package Inserts
IFU
- IVD Rev. 1.0 (CMC13531010)
Have a different keycode?
Click Here
Learn how to obtain your SDS
Ordering Information
For in vitro diagnostic (IVD) use in USA
| 0.1 mL concentrate | 135R-14 |
| 0.5 mL concentrate | 135R-15 |
| 1.0 mL concentrate | 135R-16 |
| 1.0 mL predilute ready-to-use | 135R-17 |
| 7.0 mL predilute ready-to-use | 135R-18 |
For in vitro diagnostic (IVD) use in Canada
| 0.1 mL concentrate | 135R-14 |
| 0.5 mL concentrate | 135R-15 |
| 1.0 mL concentrate | 135R-16 |
| 1.0 mL predilute ready-to-use | 135R-17 |
| 7.0 mL predilute ready-to-use | 135R-18 |
For in vitro diagnostic (IVD) use in Europe
| 0.1 mL concentrate | 135R-14 |
| 0.5 mL concentrate | 135R-15 |
| 1.0 mL concentrate | 135R-16 |
| 1.0 mL predilute ready-to-use | 135R-17 |
| 7.0 mL predilute ready-to-use | 135R-18 |
For research use only (RUO) in Japan
| 0.1 mL concentrate (RUO) | 135R-14-RUO |
| 0.5 mL concentrate (RUO) | 135R-15-RUO |
| 1.0 mL concentrate (RUO) | 135R-16-RUO |
| 1.0 mL predilute ready-to-use (RUO) | 135R-17-RUO |
| 7.0 mL predilute ready-to-use (RUO) | 135R-18-RUO |
To request information on this product in additional countries, please click the button below.